REQUEST A DEMO
Total
USD $0.00
Search more companies

Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o. Profile Updated: April 11, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o. is a company in Poland, with a head office in Lodz. It operates in the General Medical and Surgical Hospitals industry. It was incorporated on October 24, 2017. There was a total negative growth of 51.31% in Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Papiernicza 7E
Lodz; Lodzkie; Postal Code: 92-312

Contact Details: Purchase the Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o. report to view the information.
Incorporation Date:
October 24, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Centrum Diagnostyki I Terapii Onkologicznej Plock Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
57.86%
Net Profit (Loss) for the Period
47.68%
Total assets
-51.31%
Total equity
-24.16%
Return on Equity (ROE)
-26.71%
Quick Ratio
-0%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?